Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

doi:10.1136/svn-2022-001816corr1

Article metrics

See original article:

Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850) - April 01, 2023

Correction

Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

	Abstract	Full	Pdf
Sep 2022	44	44	3
Oct 2022	109	113	30
Nov 2022	45	45	15
Dec 2022	25	25	10
Jan 2023	19	19	4
Feb 2023	57	58	27
Mar 2023	46	46	15
Apr 2023	85	86	10
May 2023	146	150	37
Jun 2023	199	202	25
Jul 2023	72	73	13
Aug 2023	107	107	17
Sep 2023	60	61	15
Oct 2023	46	46	4
Nov 2023	47	47	9
Dec 2023	63	64	15
Jan 2024	40	40	5
Feb 2024	37	37	10
Mar 2024	43	45	34
Total	1290	1308	298

Log in using your username and password

Main menu

Log in using your username and password

You are here

See original article:

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

Read the full text or download the PDF:

Log in using your username and password